Kura Oncology Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2,701.4% | – | – | – | 499.5% | -509.8% | -188.2% | -388.6% | 676.5% | -470.0% | -299.7% | -144.7% | |
| – | 16.9% | – | – | – | 0.4% | 1.7% | 1.5% | 0.8% | 2.3% | 1.9% | 1.8% | 1.7% | |
| – | 564.3% | – | – | – | 16.0% | 55.6% | 45.5% | 52.8% | 65.5% | 46.1% | 39.3% | 50.4% | |
| – | 292.2% | – | – | – | 523.8% | -142.1% | 234.6% | -213.2% | 1,083.3% | -112.2% | -202.6% | 104.6% | |
| – | 1.3% | – | – | – | 0.7% | 2.1% | 9.5% | 12.4% | 13.4% | 0.7% | 3.1% | 7.3% | |
| – | 3,322.4% | – | – | – | -176.2% | -718.8% | 385.5% | 452.8% | -372.6% | -132.7% | 441.7% | 126.1% | |
| – | 54.4% | – | – | – | 1.5% | 1.0% | 3.4% | 0.0% | 6.5% | 0.4% | 7.2% | 3.5% | |
| – | 675.4% | – | – | – | 324.7% | -1,227.6% | 200.7% | 64.3% | 310.4% | -602.3% | 149.3% | -15.2% | |
| – | -2,702.7% | – | – | – | 498.8% | -511.9% | -197.8% | -400.9% | 663.1% | -470.7% | -302.8% | -152.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.